Fund profile · Compiled from public sources

Debiopharm Innovation Fund

Switzerland · Pre-seed → Series A

Their stated focus (public profile)

Debiopharm Innovation Fund is a strategic corporate venture fund investing in startups that power pharma R&D transformation and cancer care innovation, aligned with Debiopharm's oncology and drug development mission. It focuses on three areas: Next Gen Pharma R&D (AI/big data for drug development), Clinical Trial Tech (patient-centric trial solutions), and Digital Medicine (AI-powered care and real-world data insights). The fund invests primarily at Pre-Seed/Seed and Series A stages, with a particular interest in 'Cancer Tech' — digital biomarkers, AI/ML models, digital therapeutics, and precision medicine technologies.

Stages: Pre-seed → Series A

Sectors: Healthtech, Life sciences, AI / ML, Computational biology

Check size: $3M – 5M (Series A initial investment)

On file: 5 partners on record · 29 companies on record

Website: debiopharm.com

This perch was compiled from public sources — filings, the fund’s own site, public write-ups. None of it is the fund’s own words.

Is this your fund? Request a correction or removal.

For founders · Find a fund

Search the funds we have on file

Looking for investors? Search the funds we have on file — what they back, where they are, and whether your raise fits. Sign in and Percy matches you to the right ones.

    Looking to claim your own fund? Start here →